EU Industrial R&D Investment Scoreboards 2011

More documents

Recommendations

Info

The relative number of fast-growing companies (4 out of 12) is much higheramong bigger EU biotech R&D investors (i.e. those represented in the 1400Scoreboard sample, most large companies) than the number found among thesmaller ones (3 out of 52 found in the EU-1000 sample, most SMEs). Thissuggests that, in this sector, fast-growth is not a particular characteristic of thesmaller companies and that, on the contrary, companies that have reached acertain critical size manage to perform better. This evidence reinforces theimportance of increasing the size of the EU biotech companies.Table 17. Fast growing companies in the Biotechnology sub-sector based in the EU(2010 figures).CompanyR&D,€mR&DCAGR3yr, %Sales,€mSalesCAGR3yr, %RD/NetSales,%Profits/Sales,%Capex/sales,%Intercell 79.9 33.8 34.2 -10.6 233.5 -21.9 11.2 408Crucell 54.6 0.9 338.2 37.0 16.1 3.0 15.1 1188MorphoSys 53.0 40.6 87.0 12.0 60.9 13.0 2.7 435Genmab 48.0 -17.4 78.2 3.2 61.4 -46.9 1.7 229Average EU 68.5 11.7 434.0 10.9 15.8 13.2 8.9 1590Source: The 2011EU Industrial R&D Investment Scoreboard.European Commission, JRC/DG RTDEmployees54The 2011 EU Industrial R&D Investment Scoreboard
Table 18. Fast growing companies in the Biotechnology sub-sector based in the US(2010 figures).CompanyR&D,€mR&DCAGR3yr, %Sales,€mSalesCAGR3yr, %RD/NetSales,%Profits/Sales,%Capex/sales,%EmployeesCelgene 833.3 43.5 2702.7 37.1 30.8 27.0 2.7 4182Gilead Sciences 789.5 22.8 5925.6 23.4 13.3 49.8 0.8 4000Genzyme 629.0 6.0 3381.1 6.0 18.6 -0.4 14.4 10100UnitedTherapeutics 124.3 26.0 450.1 42.0 27.6 27.3 3.1 520CubistPharmaceuticals 117.7 22.8 474.4 29.3 24.8 27.5 2.7 638AmylinPharmaceuticals 114.5 -8.0 498.5 -5.0 23.0 -19.0 1400OSIPharmaceuticals 113.2 -4.9 320.1 4.6 35.4 35.4 16.1 535BiomarinPharmaceutical 109.3 42.8 280.5 45.7 39.0 -0.7 13.1 871Seattle Genetics 109.1 31.2 80.1 68.6 136.2 -63.5 3.3 348RegeneronPharmaceuticals 107.6 3.4 342.2 54.3 31.4 -21.2 21.7 1395AlexionPharmaceuticals 73.3 15.8 403.2 95.8 18.2 27.8 2.4 792Affymetrix 50.6 -4.2 231.6 -5.8 21.9 -3.0 2.5 918XOMA 43.3 5.7 25.1 -26.4 172.6 -203.2 1.0 230InspirePharmaceuticals 33.5 -5.6 79.3 29.8 42.2 -32.7 4.2 240Average US 194.8 8.1 854.5 12.2 22.8 23.3 5.3 1817Source: The 2011 EU Industrial R&D Investment Scoreboard.European Commission, JRC/DG RTD55The 2011 EU Industrial R&D Investment Scoreboard 55
Page 6 and 7:
Figure S1. One-year R&D investment,
Page 8: The specialisation of EU companies
Page 11 and 12: A high number of the companies in t
Page 13 and 14: 1. IntroductionThe 2011 "EU Industr
Page 15 and 16: Table 1. Profile of the 2011 Scoreb
Page 17 and 18: 2. OverviewIn the last year compani
Page 19 and 20: Survey on R&D investment by the EU
Page 21 and 22: 3. Top R&D investing companiesThis
Page 23 and 24: R&D changes driven by Mergers and A
Page 25 and 26: Dynamics of top R&D companiesEvery
Page 27 and 28: 4. R&D distribution by regionThis c
Page 29 and 30: Figure 3.R&D investment by the top
Page 31 and 32: R&D Trends of companies in Member S
Page 33 and 34: 5. R&D distribution by industrialse
Page 35 and 36: The actual contribution of an indus
Page 37 and 38: Table 8. Ranking of top 15 industri
Page 39 and 40: Those based in the US specialise in
Page 41 and 42: Figure 7. Annual growth rates of ma
Page 43 and 44: Table 10.Ranking of industrial sect
Page 45 and 46: The profitability of US companies (
Page 47 and 48: Electronic equipment / LeisureThis
Page 49 and 50: Alternative energyAs observed in pr
Page 51 and 52: 6. Fast growing companiesThis chapt
Page 53 and 54: The list of the companies showing t
Page 55 and 56: Table 15. Companies classified as f
Page 57: Oil equipment, services & distribut
Page 61 and 62: Table 20. Fast growing companies in
Page 63 and 64: 7. R&D and employmentThis chapter p
Page 65 and 66: Table 21 shows the ranking of indus
Page 67 and 68: Figure 10. One-year employment grow
Page 69 and 70: Annex 1 - Background informationThe
Page 71 and 72: Annex 2 - Description of the Scoreb
Page 73 and 74: Mergers and acquisitions involving
Page 75 and 76: • Hewlett-Packard, USA acquired 3
Page 77 and 78: Annex 3 - Methodological notesThe 2
Page 79 and 80: The database is supplemented by dat
Page 81 and 82: 1. Funding vs. activityThe focus of
Page 83 and 84: Standard (IAS) 38 “Intangible ass
Page 85 and 86: Annex 4 - List of fast growing comp
Page 87 and 88: Company Country Sector name 4-digit
Page 89 and 90: Annex 5 -EU1000List of EU1000 and n
Page 91 and 92: R&D Investment2010change10/09Net Sa
Page 109 and 110:
R&D Investment2010change10/09Net Sa
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
5.2 Ranking of the top 1000 non-EU
Page 125 and 126:
R&D InvestmentNet SalesR&D/NetSales
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
show all

EU Industrial R&D Investment Scoreboards 2011

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?